ISSN: 1538-4047
Journal Home
Journal Guideline
Cancer Biology and Therapy Q1 Unclaimed
Cancer Biology and Therapy is a journal indexed in SJR in Pharmacology and Molecular Medicine with an H index of 126. It has an SJR impact factor of 0,996 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 0,996.
Cancer Biology and Therapy focuses its scope in these topics and keywords: cancer, cells, tumor, cell, progression, proliferation, expression, melanoma, pathway, loss, ...
Type: Journal
Type of Copyright:
Languages: English
Open Access Policy:
Type of publications:
Publication frecuency: -
- €
Inmediate OANPD
Embargoed OA- €
Non OAMetrics
0,996
SJR Impact factor126
H Index64
Total Docs (Last Year)358
Total Docs (3 years)2710
Total Refs1607
Total Cites (3 years)356
Citable Docs (3 years)3.33
Cites/Doc (2 years)42.34
Ref/DocOther journals with similar parameters
Pharmacological Reviews Q1
Drug Resistance Updates Q1
Annual Review of Pharmacology and Toxicology Q1
Molecular Therapy Q1
Journal for ImmunoTherapy of Cancer Q1
Compare this journals
Aims and Scope
Best articles by citations
Maximizing early detection of esophageal squamous cell carcinoma via SILAC-proteomics
View moreStatic magnetic fields impair angiogenesis and growth of solid tumors in vivo
View moreTopotecan as a molecular targeting agent which blocks the Akt and VEGF cascade in platinum-resistant ovarian cancers
View moreAllosteric AKT inhibitors as a targeted cancer therapy
View moreInterleukin-2 gene transfer potentiates the a-galactosylceramide-stimulated antitumor effect by the induction of TRAIL in NKT and NK cells in mouse models of subcutaneous and metastatic carcinoma
View moreIn situ photoimmunotherapy: A new hope for cutaneous melanoma patients
View moreDecreased expression of ALDH5A1 predicts prognosis in patients with ovarian cancer
View moreProstate cancer genomic signature offers prognostic value
View moreSerum metabolite profiling of familial adenomatous polyposis using ultra performance liquid chromatography and tandem mass spectrometry
View moreThe C-terminus of interferon gamma receptor beta chain (IFN gammaR2) has antiapoptotic activity as a bax inhibitor
View moreIsolated cardiac peripheral primitive neuroectodermal tumor: A case report
View moreEthanol Treatment of Hepatocellular Carcinoma: High Potentials of Low Concentrations
View moreWhat accounts for the variable responses to progesterone on Schwann cells from mice and humans - the species-specific influence or the paracrine effects from the tumor microenvironment?
View moreSunitinib inhibits papillary thyroid carcinoma with RET/PTC rearrangement but not BRAF mutation
View moreRhoBTB2 (DBC2) comes of age as a multifunctional tumor suppressor
View moreIntestinal microorganisms involved in colorectal cancer complicated with dyslipidosis
View moreMinting a new class of Polo-like-kinase inhibitors
View moreA new look at molecular biology of breast cancer
View moreCyclin E and histone H3 levels are regulated by 5-fluorouracil in a DNA mismatch repair-dependent manner
View moreEpCAM: A New Therapeutic Target for an Old Cancer Antigen
View moreTargeting the checkpoint kinase WEE1: Selective sensitization of cancer cells to DNA-damaging drugs
View moreIL-6 stimulates Th2 type cytokine secretion and upregulates VEGF and NRP-1 expression in pancreatic cancer cells
View moreCapsaicin reactivates hMOF in gastric cancer cells and induces cell growth inhibition
View moreCirculating tumor cells count and characterization in a male breast cancer patient
View more
Comments